Drug Trial Radar · NCT07526974
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Nov 9, 2026
Primary completion
Aug 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Caliway Biopharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.
Conditions
- Subcutaneous Fat
Interventions
CBL-514 InjectionDrug
Provided as a ready for use injectable CBL-514 solution
0.9% Sodium ChlorideDrug
Injectable 0.9% Sodium Chloride solution as placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants achieving at least a 2-grade improvement on Patient Reported-Abdominal Fat Rating Scale (PR-AFRS) and Clinician Reported Abdominal Fat Rating Scale (CR-AFRS) in the CBL-514 group versus the placebo group.Time frame: From baseline to 4 weeks after final treatment
Locations
15 sites in 2 countries. Site status is shown where the registry gives one.
Investigational Site 1
Encinitas, California · Not yet recruiting
Investigational site 2
Aventura, Florida · Not yet recruiting
Investigational site 15
Miami, Florida · Recruiting
Investigational Site 3
Alpharetta, Georgia · Not yet recruiting
Investigational site 16
Baton Rouge, Louisiana · Recruiting
Investigational Site 4
Hunt Valley, Maryland · Not yet recruiting
Investigational site 5
Omaha, Nebraska · Not yet recruiting
Investigational site 6
New York, New York · Not yet recruiting
Investigational Site 7
Canal Winchester, Ohio · Not yet recruiting
Investigational site 8
Nashville, Tennessee · Not yet recruiting
Investigational site 9
Austin, Texas · Not yet recruiting
Investigational Site 10
Arlington, Virginia · Not yet recruiting
Investigational Site 11
Seattle, Washington · Not yet recruiting
Investigational Site 13
Vancouver, British Columbia, Canada · Not yet recruiting
Investigational Site 14
Woodbridge, Ontario, Canada · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.